| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Funder | Competition | Research | Implementation/Clinical Care | KX/ Travel | Education | Open to projects outside of Canada? | Lead must be based in Canada? | Key words | Due date | Max value | Currency | Length (months) | Website | ||||||||||||
2 | Health Research BC | Research Trainee Program | Y | Y | Provides post-doctoral fellows based at BC institutes with salary supporrt and a research/travel allowance. | Registration: Nov 27, 2025; Full Application: January 29, 2026 | 180,000 | CAD | 36 | https://healthresearchbc.ca/fundingprogram/research-trainee-program/ | ||||||||||||||||
3 | CIHR | Operating Grant : Advancing 2S/LGBTQI+ Health Through Research | Y | N | N | N | N | Y | For research that advances high-impact, evidence-informed research, broaden the scope and disciplinary reach of 2S/LGBTQI+ health research, strengthen collaborative capacity between researchers and communities, and support knowledge mobilization that drives policy and systems change. | Registration: Feb 11, 2026; Full: Mar 19, 2026 | 700,000 | CAD | 48 | https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=4428&view=currentOpps&org=CIHR&type=EXACT&resultCount=25&sort=program&next=1&all=1&masterList=true#objective | ||||||||||||
4 | Wellcome Trust | Wellcome Early-Career Awards | Y | N | N | N | Y | N | LMIC or UK-only; Completed PhD or 4yr equivalent research experience; PDF <3 yr; Potential to improve human health; Incl salary | Feb 17, 2026 | 400,000 | GPD | 60 | https://wellcome.org/grant-funding/schemes/early-career-awards | ||||||||||||
5 | CIHR/European Partnership on One Health AMR | Operating Grant : EUP OHAMR Joint Transnational Call 2026 | Y | N | N | N | Y | N | Research to assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use (call includes other focus areas, but CIHR is only funding proposals in this topic). Teams must include at least two partners from EU Member States or Associated Countries. | Pre-Proposal: Feb 2, 2026; Full Application: Jun 17, 2026 | 600,000 (for Canadian team; total budget dependent on all partners) | CAD | 36 | https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=4427&view=currentOpps&org=CIHR&type=EXACT&resultCount=25&sort=program&all=1&masterList=true&language=E | ||||||||||||
6 | CEPI | Innovations to Prepare for Future Epidemics and Pandemics | Y | N | N | N | Y | N | To develop innovative analytical technologies for vaccines that reduce vaccine development, manufacturing, and release times, lower costs, improve equitable deployment in LMICs, and enhance analytical insights for vaccines such as RNA, viral vectors, or protein-based vaccines. | Feb 28, 2026 | 200,000 or 800,000 | USD | 12 or 18 | https://cepi.my.site.com/call-for-proposal?id=a1zP300000331AjIAI | ||||||||||||
7 | Human Frontier Science Program | Research Grants - Early Career | Y | N | N | N | Y | N | Innovative basic life sciences research; Interdisciplinary; International teams; No inter-institutional collaboration | LOI Initiation: Mar 17, 2026 LOI Submission: Mar 26, 2026 | 900,000-1,500,000 | USD | 36 | https://www.hfsp.org/funding/hfsp-funding/research-grants | ||||||||||||
8 | Human Frontier Science Program | Research Grants - Program | Y | N | N | N | Y | N | Innovative, novel basic life sciences research; Interdisciplinary; International teams; No inter-institutional collaboration | Mar (LOI) | 600,000-1,500,000 | USD | 36 | https://www.hfsp.org/funding/hfsp-funding/research-grants | ||||||||||||
9 | NIH | Mobile Health: Technology and Outcomes in Low and Middle Income Countries (mHealth) | y | N | N | N | Y | N | Must be led by LMIC-based organization or include LMIC partner if led by a PI in the US; supports exploratory and developmental research to study the development, validation, feasibility, and effectiveness of innovative mHealth interventions or tools specifically suited for LMICs that utilize new or emerging technology, platforms, systems, or analytics. | Mar 20, 2026 | 850,000 | USD | 60 | https://grants.nih.gov/grants/guide/pa-files/PAR-25-242.html | ||||||||||||
10 | Molly Towell Perinatal Research Foundation | Molly Towell Perinatal Research Fellowship | N | N | Y | N | Non-MD | Y | Neonatal or fetal medicine; Basic or clinical research (no epidemiology or clinical trials | Mar 20, 2026 | 70,000 | CAD | 24 | https://www.mtprf.org/applications | ||||||||||||
11 | UNITAID | INSPIRE – Improving National Supply Chains for Maternal and Newborn Health (MNH) Product Access and Resource Effectiveness | N | N | Y | N | Y | Y | Seeking a project from a consortium led by a South-based organization, or with a strong representation of South-based implementers; Seeking proposals for a multi-county project that outlines specific targeted interventions to address key barriers to access to MNH products. | Mar 20, 2026 | 25,000,000 | USD | 48 | https://unitaid.org/call-for-proposal/inspire-improving-national-supply-chains-for-maternal-and-newborn-health-mnh-product-access-and-resource-effectiveness/ | ||||||||||||
12 | Wellcome Trust | Wellcome Career Development Awards | Y | N | N | N | Y | N | LMIC or UK-only; Independent investigator with institutional or NGO position; Potential to improve human health | Mar 26, 2026 | 2,000,000 | GPD | 96 | https://wellcome.org/grant-funding/schemes/career-development-awards | ||||||||||||
13 | Wellcome Trust | Wellcome Discovery Awards | Y | N | N | N | Y | N | Team; LMIC or UK-only established researcher; Co-applicants from anywhere; Potential to improve human health | Mar 31, 2026 | GPD | 96 | https://wellcome.org/grant-funding/schemes/discovery-awards | |||||||||||||
14 | UNITAID | Accelerating Cervical Cancer Elimination through Secondary Prevention in Low- and Middle-Income Countries | N | Y | Y | Y | Y | N | Primarily looking for proposals from South-based lead implementers (i.e. organizations that are headquartered in a low- or middle-income country); aim is to accelerate access to cervical cancer prevention and treatment services, with a particular focus on secondary prevention | April 9, 2026 | 30,000,000 total funding for all projects | USD | 36 - 60 | https://unitaid.org/call-for-proposal/accelerating-cervical-cancer-elimination-through-secondary-prevention-in-low-and-middle-income-countries/ | ||||||||||||
15 | Health Research BC | Match Funding | Y | N | N | N | N | Y | Applying to peer-reviewed, non-BC-government-funded research competition that requires match funding; Link to human health; Must be used in BC | 5 weeks before competition deadline | https://healthresearchbc.ca/match-funding/ | |||||||||||||||
16 | NIH | Global Infectious Disease Research Training (GID) | Y | Y | N | Y | Y | N | Open to US institutions with LMIC partner or to LMIC institutions. Application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). | August 6, 2026 | 230,000 | USD | 60 | https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html | ||||||||||||
17 | Horizon Europe - EDCTP3 | Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence | Y | Y | N | N | Y | N | Should contribute to strengthening clinical human capital base in R&I, enhancing talent retention, knowledge sharing of best practices within the research and innovation landscape, accelerate integration of digital tools into health systems, expand and scale up validated innovations with tangible implementation at national and/or sub-regional levels. | September 2, 2026 | 15,000,000 - 18,000,000 | EUR | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02?keywords=HORIZON-JU-GH-EDCTP3-2026&isExactMatch=true&status=31094501,31094502,31094503&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate | |||||||||||||
18 | CEPI | Innovations to Prepare for Future Epidemics and Pandemics | Y | N | N | N | Y | N | For (1) innovative vaccine platforms that can transform outbreak response to Disease X, addressing needs for speed, safety/efficacy, and access; or (2) advance new vaccine candidates for CEPI priority pathogens and viral families. | Rolling until 2026 | 5,000,000 | USD | 36 - 60 | https://cepi.net/calls-for-proposals?selectedProposal=9bde4615-b7b1-5f00-a079-a3080e88a845&selectedProposal=c08cff7c-f002-506a-8afb-cc2e921056ae | ||||||||||||
19 | Addax & Oryx Foundation | N/A | N | Y | N | N | Y | N | Low success rate (1%); Root causes of poverty; Africa and Middle East; Non-profit/NGO-led; Local community involvement; Holistic (Health, education, community development, environment) | Rolling | https://addax-oryx-foundation.org/en/submit-a-project | |||||||||||||||
20 | Humanitarian Grand Challenge | Transition to Scale | Y | N | N | N | Y | N | Humanitarian crises; Health supplies and equipment; WASH; Access to data; Energy | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
21 | Grand Challenges Canada | Transition to Scale | Y | Y | N | N | Y | N | Scaling innovations in Maternal and Newborn Health, Digital Health, Medical Products and Technology, Community Health Worker Models, Urban Sanitation & Hygiene, and Options for safe pregnancy termination; Requires match-funding' SSA-led | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
22 | Roncalli International Foundation | Grant | N | Y | N | Y | Y | Y | Requires Canadian organization to receive funds, but partnership with implementing community | Rolling | 35,000 | CAD | 12 | https://roncalli.ca/en/grant-application/eligibility-criteria/ | ||||||||||||
23 | Nestle Foundation | Pilot Grants | Y | N | N | Y | Y | N | LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
24 | Nestle Foundation | Small Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 50,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
25 | Nestle Foundation | Large Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 300,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
26 | Nestle Foundation | Training Grant | Y | N | N | Y | Y | N | MSc or PhD Student; LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
27 | Nestle Foundation | Re-entry Grants | Y | N | N | N | Y | N | LMIC-based; Supports return to home country; Needs support from host institution | Rolling | 50,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
28 | Commonweath Fund | Project Grants | Y | Y | N | N | Y | N | Primarily US-focused; Global priorities include: models of effective primary care, policy solutions to improve health care affordability , and partners with access to data sets to complete international comparisons of access, cost, and quality of care. Clinical, policy, or implementation research | Rolling | 180,000 | USD | 12 | https://www.commonwealthfund.org/grants | ||||||||||||
29 | Fonds d'Innovation pour le Developpement | Preperation Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; For preparing for pilot or preperation for scaling grant | Rolling | 50,000 | EUR | 6 | https://fundinnovation.dev/en/launch-project | ||||||||||||
30 | Fonds d'Innovation pour le Developpement | Pilot Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Testing innovations in real-world environment | Rolling | 200,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
31 | Fonds d'Innovation pour le Developpement | Test and Preparation for Scaling Up | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; ; Testing for impact on larger scale and evaluating cost-effectiveness | Rolling | 1,500,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
32 | Fonds d'Innovation pour le Developpement | Scaling Up | Y | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; Implementation following rigorous evidence of impact and cost-effectiveness | Rolling | 4,000,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
33 | Fonds d'Innovation pour le Developpement | Transformatiom of Public Policies | N | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Institutionalizing innovations or building capacity of governements to design, test, and evalution innovations | Rolling | 500,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
34 | Founders Pledge | Global Health and Development Fund | N | Y | N | N | Y | N | Implementation, not research. Global health and development programs, especially programs that can, in expectation, save a life for under $4,000, avert a DALY for under $70, or double income for one person at a cost of less than $30. Note that this includes interventions that affect economic growth. We don’t necessarily require that grantees be able to point to an RCT in order to demonstrate cost-effectiveness | Rolling | 300,000 | USD | https://www.founderspledge.com/requests-for-funding | |||||||||||||
35 | Open Philanthropy | Grants - Global Health and Wellbeing: Scientific Research | Y | N | N | N | Y | N | Current topics of interest include road-spectrum antiviral drugs, vaccine development, basic immunology, some aspects of cardiovascular disease, Alzheimer’s disease, predicting mouse-to-human translation, control of inflammation, epigenetics, novel scientific tools and methods, malaria, and research on how biomedical research may be improved. | Rolling | 50,000 - 2,600,000 | USD | https://www.openphilanthropy.org/focus/scientific-research/ | |||||||||||||
36 | ||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |